4/2/2014 | SPRING meeting Bid inhibits the Rip1-Mediated Necrotic Pathway | 9455 MRB IV | Patrice Wagner |
4/4/2014 | CRISPR Interest Group | MRBIII Room 3131 | None provided |
10/30/2014 | Flexner Discovery Lecture Series CellNet: Enhancing Cellular Engineering Through Network Biology | 208 Light Hall | George Q. Daley, MD, PhD |
11/12/2014 | Beta Cell Interest Group (BIG) Seminar “The Characterization of MafB in Adult β-cells" | 512 Light Hall | Holly Cyphert (Stein) |
4/2/2015 | Flexner Discovery Lecture Series Human Obesity and Insulin Resistance: Lessons from the Extremes | 208 Light Hall | Sir Stephen O'Rahilly, MD, FRCP, FRCPI, FRCPath |
4/23/2015 | Flexner Discovery Lecture Series | 208 Light Hall | Roel Nusse, PhD |
10/19/2015 | VCSCB/CDB Seminar Series "Overcoming Impediments to Cellular Reprogramming" | 1220 MRB III | Ken Zaret, Ph.D. |
12/2/2015 | SPRING Meeting Reprogramming strategy to engineer a cardiac fate | 9455 MRB IV | Young-Jae Nam, M.D., Ph.D. |
1/21/2016 | Flexner Discovery Lecture Series Opening Doors Worldwide through Medical Science | 208 Light Hall | Peter Agre, M.D. |
1/28/2016 | Flexner Discovery Lecture Series Intention-to-Treat Analysis with Treatment Discontinuation and Missing Data in Clinical Trials | 208 Light Hall | Roderick J.A. Little, Ph.D. |
2/25/2016 | Flexner Discovery Lecture Series The Essential Role of Bioinformatics in Exploring the World of Proteins and Characterizing the Human Proteome | 208 Light Hall | Gilbert S. Omenn, M.D., Ph.D. |
5/5/2016 | Flexner Discovery Lecture Series Linking Metabolism to Stem Cell Maintenance | 208 Light Hall | Craig B. Thompson, M.D. |
3/20/2017 | VCSCB/CDB Seminar Series Chemical control of endogenous stem cells for treatment of myelin disorders | 1220 MRB III | Paul Tesar, Ph.D. |
5/19/2022 | 2022 VCSCB Symposium - Stem Cell States and Transitions | Wilson Hall Auditorium & Lobby | None provided |